425: Strive, Semler Scientific Merger Communication

Strive Inc. filed a Form 425 communication regarding its proposed business combination with Semler Scientific, emphasizing forward-looking statements and associated risks.

Summary

• Strive, Inc. filed a Form 425 communication concerning its proposed business combination with Semler Scientific, Inc.
• The communication was reposted on X.com by Matthew Cole, CEO of Strive, on December 11, 2025.
• The filing includes a cautionary statement regarding forward-looking statements related to the proposed transaction.
• Forward-looking statements cover the outlook and expectations of both companies, strategic and financial benefits, the timing of closing, and the ability to successfully integrate the combined businesses.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement on Form S-4 and the Information Statement/Proxy Statement/Prospectus for important information before making any voting or investment decision.

Sentiment

Score: 5

Explanation: The filing is neutral, primarily serving as a cautionary statement about a proposed merger. While it mentions potential benefits, it heavily emphasizes numerous risks and uncertainties, balancing any positive sentiment with a strong focus on potential negative outcomes and procedural requirements.

Positives

• The proposed transaction is expected to yield strategic benefits for the combined company.
• The proposed transaction is expected to result in financial benefits for the combined company.
• The proposed transaction is anticipated to positively impact the combined company's future financial performance.

Risks

• The occurrence of any event, change, or circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including anticipated cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact the transaction.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities due to the transaction.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other unknown or unpredictable factors could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The filing outlines expectations for the proposed transaction, including anticipated strategic and financial benefits, the timing of closing, and the successful integration of the combined businesses. However, it heavily emphasizes that these are forward-looking statements subject to significant risks and uncertainties, and actual results may differ materially from any projected future results.

Management Comments

• Matthew Cole, Chief Executive Officer of Strive, reposted the communication on X.com on December 11, 2025.
• Management of both Strive and Semler Scientific believe that their expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of their existing knowledge of their business and operations.

Industry Context

This filing is a standard regulatory communication regarding a proposed merger, common in industries undergoing consolidation or strategic shifts. The explicit mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' suggests a potential strategic direction for the combined entity that aligns with emerging trends in corporate finance and digital asset integration, particularly relevant for companies exploring alternative treasury management strategies.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is a potential risk.

Stakeholder Impact

• Shareholders of Strive may experience dilution due to the issuance of additional shares of its Class A common stock.
• Customers and employees of both Strive and Semler Scientific may have adverse reactions or changes to business or employee relationships as a result of the announcement or completion of the proposed transaction.

Next Steps

• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific.
• Semler Scientific stockholders will be asked to approve the proposed transaction.
• Strive and Semler Scientific may file other relevant documents concerning the proposed transaction with the SEC.
• The proposed transaction will close upon the satisfaction of all conditions.

Key Dates

Keywords

Strive, Semler Scientific, merger, business combination, SEC filing, Form 425, forward-looking statements, risk factors, corporate governance, Bitcoin treasury, digital assets